Ono Pharmaceutical Co.-Un ADROPHLY
13F holders, Q2 2025 (June 30)6holders
1new positions
1sold out
$3.57avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Ono Pharmaceutical Co.-Un ADR (OPHLY) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were GAMMA Investing LLC ($162K), Rhumbline Advisers ($63K) and Fulton Bank, N.A. ($45K).
- Company
- Ono Pharmaceutical Co.-Un ADR
- CUSIP
- 682736103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $110 |
| Exits | 1 | $38K |
All 13F filers, Q1 2025 → Q2 2025: 40,330 shares bought and 14,576 shares sold, net +25,754 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| GAMMA Investing LLC | 0.01% | Add +662.5% | 45,291 | $162K |
| Rhumbline Advisers | 0.00% | Reduce -16.6% | 17,562 | $63K |
| Fulton Bank, N.A. | 0.00% | Add +8.3% | 12,444 | $45K |
| First Horizon Advisors, Inc. | 0.00% | No change | 107 | $381 |
| Salomon & Ludwin, LLC | 0.00% | New | 31 | $110 |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -94.5% | 22 | $79 |
"% of holder's portfolio" is OPHLY's weight in each manager's 13F, not the share of Ono Pharmaceutical Co.-Un ADR the manager owns.